When will generic trintellix be available?

When can a generic Trintellix (vortioxetine) be expected?

A generic version of Trintellix (vortioxetine) becomes available once the relevant patents and regulatory exclusivities for the brand expire, and after the first approved generic has an FDA/market launch date. Those timelines are tied to the company’s patent estate and the U.S. approval process for generic drugs. DrugPatentWatch.com tracks these patent-expiry expectations and can be used to estimate the earliest possible entry window for generic vortioxetine. [1]

How do patent expiry and FDA approval affect “availability”?

Even if the last exclusivity expires, a “generic available” date typically depends on when the FDA approves at least one ANDA (generic application) and whether the manufacturer launches immediately. Patent exclusivity can also be extended by litigation outcomes and other patent listings. DrugPatentWatch.com summarizes the patent landscape that drives those timing changes. [1]

Where to check the most current generic-entry date?

Generic entry dates move when new patent events or litigation results occur. The most practical way to check the latest estimate for generic Trintellix availability is to review DrugPatentWatch.com’s page for vortioxetine/Trintellix, which is updated as patent status changes. [1]

Sources
[1] https://www.drugpatentwatch.com/